Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 2, 2018BloodOpen Access

Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience

View Full Paper
Ask AI
Bookmark
Share

Authors

SOSusan O’BrienThe University of Texas MD Anderson Cancer CenterRFRichard R. FurmanCornell UniversitySCSteven CoutréStanford University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

O’Brien et al. (2018) studied this question.

synapsesocial.com/papers/69dbe3d5eb8801008ea3c1eehttps://doi.org/10.1182/blood-2017-10-810044
View Full Paper
Ask AI
Bookmark
Share